Cargando…
MUC1-C intersects chronic inflammation with epigenetic reprogramming by regulating the set1a compass complex in cancer progression
Chronic inflammation promotes epigenetic reprogramming in cancer progression by pathways that remain unclear. The oncogenic MUC1-C protein is activated by the inflammatory NF-κB pathway in cancer cells. There is no known involvement of MUC1-C in regulation of the COMPASS family of H3K4 methyltransfe...
Autores principales: | Bhattacharya, Atrayee, Fushimi, Atsushi, Wang, Keyi, Yamashita, Nami, Morimoto, Yoshihiro, Ishikawa, Satoshi, Daimon, Tatsuaki, Liu, Tao, Liu, Song, Long, Mark D., Kufe, Donald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567710/ https://www.ncbi.nlm.nih.gov/pubmed/37821650 http://dx.doi.org/10.1038/s42003-023-05395-9 |
Ejemplares similares
-
MUC1-C is a master regulator of MICA/B NKG2D ligand and exosome secretion in human cancer cells
por: Morimoto, Yoshihiro, et al.
Publicado: (2023) -
MUC1-C integrates aerobic glycolysis with suppression of oxidative phosphorylation in triple-negative breast cancer stem cells
por: Yamashita, Nami, et al.
Publicado: (2023) -
MUC1-C dictates neuroendocrine lineage specification in pancreatic ductal adenocarcinomas
por: Luan, Zhou, et al.
Publicado: (2021) -
Dependence on the MUC1-C Oncoprotein in Classic, Variant, and Non–neuroendocrine Small Cell Lung Cancer
por: Fushimi, Atsushi, et al.
Publicado: (2022) -
Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment
por: Morimoto, Yoshihiro, et al.
Publicado: (2022)